Nuveen Asset Management, LLC Verastem, Inc. Transaction History

Nuveen Asset Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.02 - $1.83 $522,605 - $937,615	-512,358 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.06 - $2.1 $8,058 - $15,964	7,602 Added 1.51%	512,358 $651,000
Q4 2021 Feb 14, 2022	SELL	$2.05 - $3.2 $84,683 - $132,188	-41,309 Reduced 7.56%	504,756 $1.12 Million
Q3 2021 Nov 12, 2021	SELL	$2.54 - $4.07 $179,252 - $287,228	-70,572 Reduced 11.44%	546,065 $1.51 Million
Q2 2021 Aug 16, 2021	SELL	$2.57 - $4.85 $211,300 - $398,757	-82,218 Reduced 11.76%	616,637 $2.51 Million
Q1 2021 May 17, 2021	SELL	$1.9 - $2.82 $56,188 - $83,395	-29,573 Reduced 4.06%	698,855 $1.73 Million
Q4 2020 Feb 16, 2021	BUY	$1.15 - $2.4 $28,321 - $59,104	24,627 Added 3.5%	728,428 $1.55 Million
Q3 2020 Nov 16, 2020	BUY	$1.11 - $1.68 $3,008 - $4,552	2,710 Added 0.39%	703,801 $851,000
Q2 2020 Aug 14, 2020	BUY	$1.69 - $4.2 $1.18 Million - $2.94 Million	701,091 New	701,091 $1.21 Million

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $840M
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.